Published 2025-01-01
“…Xiaoyong Miao,1,* Jianing Zhang,2,* Weiyan Huang,2,*
Yifei Wang,1 Aixia Jin,1 Jianping
Cao,1 Zhenzhen Zhao3 1Department of Anesthesiology, Naval Medical Center, Naval Medical University, Shanghai, People’s Republic of China; 2Student Brigade, Changhai Hospital, Naval Medical University, Shanghai, People’s Republic of China; 3Department of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zhenzhen Zhao, Department of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, 200433, People’s Republic of China, Email zpluto@163.com Jianping
Cao, Department of Anesthesiology, Naval Medical Center, Naval Medical University, Shanghai, 200050, People’s Republic of China, Email cjpcl221019@sina.comAbstract: Sodium glucose co-transporter 2 (SGLT2) inhibitors represent a novel class of hypoglycemic drugs that have emerged in recent years. …”
Get full text
Article